Rossari Biotech

44
Sell
  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE02A801020
  • NSEID: ROSSARI
  • BSEID: 543213
INR
512.75
-13.75 (-2.61%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 37.46 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
2,396.00
2,080.00
1,830.00
1,655.00
1,482.00
709.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,396.00
2,080.00
1,830.00
1,655.00
1,482.00
709.00
Expenditure (Ex Depriciation)
Stock Adjustments
-28.00
-31.00
-63.00
-12.00
-20.00
-8.00
Raw Materials Consumed
1,697.00
1,464.00
1,357.00
1,183.00
1,125.00
470.00
Power & Fuel Cost
26.00
25.00
0.00
0.00
0.00
0.00
Employee Cost
154.00
132.00
103.00
98.00
67.00
41.00
Operating Expenses
130.00
112.00
86.00
72.00
64.00
31.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
35.00
33.00
18.00
22.00
12.00
21.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
12.00
13.00
12.00
10.00
12.00
10.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,110.00
1,815.00
1,580.00
1,432.00
1,299.00
585.00
Operating Profit (PBDIT) excl Other Income
285.00
265.00
249.00
223.00
183.00
123.00
Other Income
22.00
4.00
7.00
5.00
11.00
8.00
Operating Profit (PBDIT)
308.00
269.00
257.00
228.00
195.00
132.00
Interest
28.00
17.00
19.00
22.00
12.00
2.00
Profit before Depriciation and Tax
279.00
251.00
237.00
206.00
182.00
129.00
Depreciation
79.00
67.00
60.00
62.00
48.00
22.00
Profit Before Taxation & Exceptional Items
200.00
184.00
177.00
143.00
134.00
106.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
202.00
185.00
177.00
144.00
136.00
106.00
Provision for Tax
53.00
48.00
46.00
36.00
38.00
26.00
Profit After Tax
147.00
135.00
130.00
106.00
96.00
79.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
697.00
564.00
436.00
331.00
238.00
160.00
Profit Available for appropriations
846.00
700.00
567.00
439.00
336.00
241.00
Appropriations
846.00
700.00
567.00
439.00
336.00
241.00
Equity Dividend (%)
25.00%
25.00%
25.00%
25.00%
25.00%
25.00%
Earnings Per Share
26.95
24.66
23.67
19.46
17.81
15.56
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 15.19% vs 13.64% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 7.85% vs 6.14% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 60.25% vs -8.06% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 8.80% vs 3.74% in Mar 2025

Compare Profit and Loss Results of Rossari Biotech
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,396.00
1,276.00
1,120.00
87.77%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,396.00
1,276.00
1,120.00
87.77%
Expenditure (Ex Depriciation)
Stock Adjustments
-28.00
-11.00
-17.00
-154.55%
Raw Materials Consumed
1,697.00
859.00
838.00
97.56%
Power & Fuel Cost
26.00
40.00
-14.00
-35.00%
Employee Cost
154.00
62.00
92.00
148.39%
Operating Expenses
130.00
16.00
114.00
712.50%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
35.00
35.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
12.00
24.00
-12.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,110.00
1,059.00
1,051.00
99.24%
Operating Profit (PBDIT) excl Other Income
285.00
216.00
69.00
31.94%
Other Income
22.00
38.00
-16.00
-42.11%
Operating Profit (PBDIT)
308.00
255.00
53.00
20.78%
Interest
28.00
0.00
28.00
0%
Profit before Depriciation and Tax
279.00
255.00
24.00
9.41%
Depreciation
79.00
8.00
71.00
887.50%
Profit Before Taxation & Exceptional Items
200.00
246.00
-46.00
-18.70%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
202.00
247.00
-45.00
-18.22%
Provision for Tax
53.00
67.00
-14.00
-20.90%
Profit After Tax
147.00
179.00
-32.00
-17.88%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
697.00
953.00
-256.00
-26.86%
Profit Available for appropriations
846.00
1,133.00
-287.00
-25.33%
Appropriations
846.00
1,133.00
-287.00
-25.33%
Equity Dividend (%)
25%
400%
-375.00
Earnings Per Share
26.95
7.24
19.71
272.24%
Profit And Loss - Net Sales
Net Sales 2,396.36 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 15.19% vs 13.64% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 285.90 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 7.85% vs 6.14% in Mar 2025

Profit And Loss - Interest
Interest 28.54 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 60.25% vs -8.06% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 147.31 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 8.80% vs 3.74% in Mar 2025